- Home
- ATNF vs KTTA Comparison
ATNF vs KTTA Comparison
Compare ATNF & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNF
- KTTA
- Stock Information
- Founded
- ATNF 2016
- KTTA 2020
- Country
- ATNF United States
- KTTA United States
- Employees
- ATNF N/A
- KTTA N/A
- Industry
- ATNF Biotechnology: Pharmaceutical Preparations
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- ATNF Health Care
- KTTA Health Care
- Exchange
- ATNF Nasdaq
- KTTA Nasdaq
- Market Cap
- ATNF 5.0M
- KTTA 5.1M
- IPO Year
- ATNF N/A
- KTTA 2021
- Fundamental
- Price
- ATNF $3.52
- KTTA $0.73
- Analyst Decision
- ATNF
- KTTA
- Analyst Count
- ATNF 0
- KTTA 0
- Target Price
- ATNF N/A
- KTTA N/A
- AVG Volume (30 Days)
- ATNF 6.6M
- KTTA 106.9K
- Earning Date
- ATNF 07-23-2025
- KTTA 08-12-2025
- Dividend Yield
- ATNF N/A
- KTTA N/A
- EPS Growth
- ATNF N/A
- KTTA N/A
- EPS
- ATNF N/A
- KTTA N/A
- Revenue
- ATNF N/A
- KTTA N/A
- Revenue This Year
- ATNF N/A
- KTTA N/A
- Revenue Next Year
- ATNF N/A
- KTTA N/A
- P/E Ratio
- ATNF N/A
- KTTA N/A
- Revenue Growth
- ATNF N/A
- KTTA N/A
- 52 Week Low
- ATNF $0.66
- KTTA $0.65
- 52 Week High
- ATNF $17.75
- KTTA $7.50
- Technical
- Relative Strength Index (RSI)
- ATNF 78.48
- KTTA 46.27
- Support Level
- ATNF $2.55
- KTTA $0.70
- Resistance Level
- ATNF $4.75
- KTTA $0.75
- Average True Range (ATR)
- ATNF 0.81
- KTTA 0.04
- MACD
- ATNF 0.21
- KTTA 0.01
- Stochastic Oscillator
- ATNF 68.24
- KTTA 60.30
About ATNF 180 Life Sciences Corp.
180 Life Sciences Corp was formed as a clinical-stage biotechnology company, focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation, and fibrosis by employing research, and, where appropriate, combination therapy. In addition, it has acquired certain source code and intellectual property relating to the back-end technology platform to operate an online blockchain casino, and moving forward, it plans to focus the majority of its operations on the creation of the online blockchain casino, while looking to monetize certain prior development-stage therapeutic product candidates for unmet medical needs. It has one reportable operating segment, iGaming.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).